Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection

  • Authors : NCT04342663

  • Source: https://clinicaltrials.gov/show/NCT04342663 2020This document should be cited as: NCT04342663. A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection

  • Abstract: We will consent approximately 152 participants, age 18 and older, who have tested tested positive for COVID-19 and are currently experiencing mild symptoms. ...

Record details

×

A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19

  • Authors : NCT04469621

  • Source: https://clinicaltrials.gov/show/NCT04469621 2020This document should be cited as: NCT04469621. A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 2020 (The Cochrane

  • Abstract: Study duration per participant is approximatively 32 days including a 14-day treatment period

Record details

×

A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19

  • Authors : NCT04415073

  • Source: https://clinicaltrials.gov/show/NCT04415073 2020This document should be cited as: NCT04415073. A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19

  • Abstract: Axatilimab (SNDX-6352) is a humanized IgG4 monoclonal antibody with high affinity against CSF-1R under investigation for the prevention or treatment of respiratory signs and ...

Record details

×

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

  • Authors : NCT04540185

  • Source: https://clinicaltrials.gov/show/NCT04540185 2020This document should be cited as: NCT04540185. A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 2020 (The

  • Abstract: Early clinical studies showed that besides protecting against poliomyelitis, oral polio vaccine (OPV) reduced the number of other viruses that could be isolated from immunized ...

Record details

×

A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19

  • Authors : NCT04382040

  • Source: https://clinicaltrials.gov/show/NCT04382040 2020This document should be cited as: NCT04382040. A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19

  • Abstract: STUDY OBJECTIVES This study is designed to evaluate the safety and efficacy of ArtemiC on patients diagnosed with COVID-19.STUDY TREATMENT ...

Record details

×

A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic

  • Authors : NCT04444700

  • Source: https://clinicaltrials.gov/show/NCT04444700 2020This document should be cited as: NCT04444700. A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to

  • Abstract: Published papers evaluating coagulopathy on COVID-19 patients indicate a higher incidence of thromboembolic events, sometimes, as high as 20%. Such events increase ...

Record details

×

A Randomised Controlled Trial of Early Intervention in COVID-19: favipiravir Verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe

  • Authors : NCT04373733

  • Source: https://clinicaltrials.gov/show/NCT04373733 2020This document should be cited as: NCT04373733. A Randomised Controlled Trial of Early Intervention in COVID-19: favipiravir Verses HydroxycholorquiNe & Azithromycin &

  • Abstract: A prospective, randomised, open label study of the combined use of azithromcycin, hydroxychloroquine, zinc and standard clinical care verses favipiravir and standard clinical care verses ...

Record details

×

A Study for Outpatients With COVID-19

  • Authors : NCT04518410

  • Source: https://clinicaltrials.gov/show/NCT04518410 2020This document should be cited as: NCT04518410. A Study for Outpatients With COVID-19 2020 (The Cochrane Controlled Trials Register (CCTR/CENTRAL). Oxford:

  • Abstract: This is a master protocol to evaluate the safety and efficacy of multiple investigational agents aimed at modifying the host immune response to SARS-CoV-2 infection, ...

Record details

×

A Study of a Candidate COVID-19 Vaccine (COV001)

  • Authors : NCT04324606

  • Source: https://clinicaltrials.gov/show/NCT04324606 2020This document should be cited as: NCT04324606. A Study of a Candidate COVID-19 Vaccine (COV001) 2020 (The Cochrane Controlled Trials Register (CCTR/CENTRAL).

  • Abstract: There will be 5 study groups and it is anticipated that a total of 510 volunteers will be enrolled. Volunteers will participate in the study for approximately 6 ...

Record details

×

A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

  • Authors : NCT04402060

  • Source: https://clinicaltrials.gov/show/NCT04402060 2020This document should be cited as: NCT04402060. A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 2020 (The Cochrane Controlled Trials Register

  • Abstract: The purpose of this study is to evaluate the safety and effectiveness of APL-9 in adults with mild to moderate ARDS (acute respiratory distress syndrome) ...

Record details

×
  • 1-10 of  144,746 results for "COVID-19"